FDA Approves New Stem Cell Line
Advanced Cell Technology (ACT), of Marlborough, Mass., announced that it has received FDA approval to begin treating children with Stargardt's macular dystrophy using retinal cells derived from ESCs.
(Photo: A fluorescent microscope image shows human embryonic stem cells at Stanford University March 9, 2009/California Institute for Regenerative Medicine)
HHS Releases New Insurance Rule
HHS Releases Final Medical Loss Ratio Regulations
So Long, Darvon and Darvocet: FDA Requests Pain Meds Be Pulled
Has The Obama Administration Created a Monster